Glasgow (United Kingdom of Great Britain & Northern Ireland)
ESC Congress 2021 - The Digital Experience
Risk Factors and Prevention
Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?
ESC CONGRESS 2016
Addressing cardiovascular risk in type 2 diabetes - The LEADER trial